Navigation Links
MedCath Corporation Reports Third Quarter Earnings
Date:8/5/2009

0.03 $0.25 $0.22 $0.62 Discontinued operations (0.00) 0.35 0.20 0.38 ----- ---- ---- ---- Earnings per share, diluted $0.03 $0.60 $0.42 $1.00 ----- ----- ----- ----- Weighted average number of shares, basic 19,733 19,524 19,665 20,415 Dilutive effect of stock options and restricted stock - 107 56 89 --- --- --- --- Weighted average number of shares, diluted 19,733 19,631 19,721 20,504 ====== ====== ====== ====== MEDCATH CORPORATION CONSOLIDATED BALANCE SHEETS (In thousands, except share data) June 30, September 30, 2009 2008 ---- ---- (Unaudited) Current assets: Cash and cash equivalents $42,857 $93,836 Restricted cash 3,166 3,154 Accounts receivable, net 76,205 83,875 Income tax receivable, net 3,940 3,091 Medical supplies 18,335 15,479 Deferred income tax assets 7,600 9,769 Prepaid expenses and other current assets 12,235 9,796 Current assets of discontinued operations 10,052 20,776
'/>"/>
SOURCE MedCath Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
2. MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
3. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
4. MedCath Corporation to Hold Conference Call on First Quarter Results
5. MedCath Corporation Reports First Quarter Earnings
6. MedCath Plans 60-bed Expansion at TexSAn Heart Hospital
7. MedCath Announces Venture With Two New Jersey Hospitals
8. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
9. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
10. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
11. MedCath Announces Acquisition of Ownership in Arizona Cath Lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015 A new Zofran ... California Superior Court on behalf of a child who ... after his mother was prescribed the anti-nausea medication during ... 6th filing in Alameda Superior Court, the baby’s mother ... that she experienced in the early months of her ...
(Date:3/30/2015)... “ iCareTech ” was featured on NewsWatch ... look at the latest and coolest technology products and services ... technology expert, conducted the review and shared with viewers how ... the medical and health fields. , Wearable technology has been ... past couple of years. Well, at CES, NewsWatch TV came ...
(Date:3/30/2015)... 30, 2015 A key protein previously ... plays an important role in the response to viral ... the Icahn School of Medicine at Mount Sinai published ... long been associated with inflammation, part of the body’s ... cells home in to attack invaders like bacteria and ...
(Date:3/30/2015)... 2015 On March 29, 2015 the United ... honor of all small business owners, for their commitment to ... , According to Zane Benefits' website, small businesses in ... 75% of all jobs and employing over 60 million people. ... of all U.S. sales. The small business sector is growing ...
(Date:3/30/2015)... 2015 Tel-Aviv – March 30, 2015 ... announced the closing of $12.5 million in new financing ... Viola Group. The funding will further GlassesUSA's aggressive business ... in the growing global market of online eyewear, both ... by CEO Daniel Rothman, COO Eldad Rothman, and CTO ...
Breaking Medicine News(10 mins):Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:Zane Benefits Puts Spotlight on Small Businesses for National Mom and Pop Business Owners Day 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... RONKONKOMA, N.Y., April 24 NBTY, Inc. (NYSE:,NTY) ... supplements, today announced results for the fiscal second,quarter and ... the fiscal second quarter ended March 31, 2008, net ... fiscal second quarter ended March,31, 2007, an increase of ...
... strengthen KePRO,s corporate infrastructure and provide ... tactical and strategic market advantages, ... Inc. (KePRO), a rapidly growing, national medical management,firm has ... senior positions. Meghan Harris, MS, is KePRO,s new Vice,President, ...
... The following are,excerpts from an article in The ... Republican National Committee:, Congressional Democrats are backing away ... saying that even if,their party controls the White House ... some senators, the promises made by Sens. Barack Obama ...
... April 24 ,The U.S. Food and Drug Administration ... Actonel(R) (risedronate sodium) tablets for the treatment,and prevention ... risk of fractures in postmenopausal women with osteoporosis., ... is based on a study comparing,Actonel 150 mg ...
... The Perrigo Company,(Nasdaq: PRGO ; TASE) today ... and Drug Administration (FDA) to market over-the-counter (OTC),Nicotine Polacrilex ... (Orange, Coated)., The FDA has determined the product ... Gum, 2 mg (base) and 4 mg,(base), which is ...
... Two ... Days of FDA Approval, ... of its,CIMplicity(TM) program, designed to enhance treatment support for patients,suffering ... their caregivers with comprehensive financial,administrative, compliance and treatment support. The ...
Cached Medicine News:Health News:NBTY Reports Second Quarter Results 2Health News:NBTY Reports Second Quarter Results 3Health News:NBTY Reports Second Quarter Results 4Health News:NBTY Reports Second Quarter Results 5Health News:NBTY Reports Second Quarter Results 6Health News:NBTY Reports Second Quarter Results 7Health News:NBTY Reports Second Quarter Results 8Health News:NBTY Reports Second Quarter Results 9Health News:NBTY Reports Second Quarter Results 10Health News:NBTY Reports Second Quarter Results 11Health News:NBTY Reports Second Quarter Results 12Health News:NBTY Reports Second Quarter Results 13Health News:NBTY Reports Second Quarter Results 14Health News:NBTY Reports Second Quarter Results 15Health News:NBTY Reports Second Quarter Results 16Health News:NBTY Reports Second Quarter Results 17Health News:NBTY Reports Second Quarter Results 18Health News:KePRO Appoints Two New IT Vice Presidents 2Health News:KePRO Appoints Two New IT Vice Presidents 3Health News:RNC: Dems Hedge on Healthcare 2Health News:FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis 2Health News:FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis 3Health News:FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis 4Health News:FDA Approves New Once-a-Month Dose of Actonel for Postmenopausal Osteoporosis 5Health News:Perrigo Receives FDA Approval to Market Orange, Coated Nicotine Gum 2Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 2Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 3Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 4Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 5Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 6Health News:UCB Launches CIMplicity(TM) Program to Enhance Treatment Support for Cimzia(R) (certolizumab pegol) Patients and Caregivers 7
(Date:3/30/2015)... March 30, 2015  BioPharmX Corporation (OTCQB: BPMX), ... of novel drug delivery products to address unmet ... announced the appointment of Stephen Morlock , ... to its board of directors.  Mr. Morlock,s background ... expand its national roll-out of Violet iodine, the ...
(Date:3/30/2015)... 30, 2015 Alere Inc. (NYSE: ALR ... following statement today in support of President Barack ... "As the global leader in rapid ... Obama for establishing a National Action Plan with ... threat of antibiotic resistance. We look forward to continuing ...
(Date:3/30/2015)... 30, 2015 Beta-O2 ... as the company,s new chief executive officer. Dr. ... leading early stage Israeli venture capital firm. He is ... and vascular surgery.        (Logo: http://photos.prnewswire.com/prnh/20140910/705638) ... Sherpa Innoventures is Beta-O2,s newest investor, having participated in ...
Breaking Medicine Technology:BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3Alere Applauds President's National Action Plan to Combat Antibiotic-Resistant Bacteria 2Beta-O2 Names Dr. Yuval Avni CEO 2Beta-O2 Names Dr. Yuval Avni CEO 3
... Legal-Bay LLC, through its website lawsuitssettlementfunding.com ... to plaintiffs in need of lawsuit cash advances ... an industry leader; however they are striving to set ... company announced that they have ramped up their operations ...
... Assured Pharmacy (Pink Sheets: APHYD ), a ... than 3,000 sufferers of chronic pain, is pleased to ... completed an audit of Assured Pharmacy,s consolidated financial statements ... financial statements have been posted on the OTC Markets ...
Cached Medicine Technology:Legal-Bay LLC Announces Opening of Jones Act Lawsuit Funding Division 2Assured Pharmacy Completes Audit of 2010 Financial Statements 2
... Anatomical Malar I Implants - Providing the ... follows the contour of the zygoma while ... Anatomical Malar II Implants - The ... surgeon with another augumentation option that adds ...
Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an ...
... The IEC CL40 and FL40 Centrifuge ... safety and versatility to increase your ... a broad array of rotors and ... and microplate applications, the IEC CL40 ...
... Thermos IEC CL31 Multispeed Series ... in a quiet, compact, 1.2 liter ... of rotors and accessories and high-speed ... offers virtually everything you need to ...
Medicine Products: